Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MD Pharma is a leading Israeli specialty pharmaceutical company focused on the registration, marketing, and distribution of innovative drugs, orphan drugs, and medical devices. Founded in 1997, the company specializes in niche therapeutic areas including oncology, hematology, neurology, and rare genetic disorders. MD Pharma serves as a strategic partner for international biotechnology firms, providing comprehensive market access services such as regulatory affairs, reimbursement strategy, and specialized logistics. The company is recognized for its expertise in managing high-value biologics and navigating the complex Israeli healthcare landscape to bring life-saving treatments to patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MD Pharma.